Swiss textile materials technology innovator HeiQ has publicly listed on the London Stock Exchange today (8 December).

The admission follows an oversubscribed placing and subscription, raising GBP60m (US$80.15m).

Founded in 2005 as a spin-off from the Swiss Federal Institute of Technology Zurich (ETH), HeiQ develops durable and high-performance textile technologies, including HeiQ Viroblock – an award-winning antimicrobial technology which helps in the fight against enveloped viruses, including SARS-Cov-2, the virus that causes Covid-19. The technology is already being used by more than 150 major brands such as Burberry.

The company's aim is to deliver growth by driving increased sales of HeiQ's core products and by entering additional lucrative markets through disruptive innovations:

  • Increasing market penetration of core innovations
  • Building on the significant momentum achieved by HeiQ Viroblock
  • Developing new disruptive innovations

"Today's listing is a major milestone for HeiQ. We have spent 15 years building HeiQ to become one of the leading textile materials innovators in the world," HeiQ co-founder and CEO, Carlo Centonze, said.

"The fundraise will enable HeiQ to capture more market share through increased sales of our core products to major brands. These have grown 17% in the first half of the year. The antimicrobial market, which has become a mainstream request, also presents a compelling growth opportunity going forward."